Aline Z.
- Country
- France
- Department
- Neurologie
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- Randomized, Double-Blind, Placebo-Controlled Study on the Efficacy of Caffeine in Cognitive Decline in Early to Moderate Alzheimer's Disease
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Intrathecal BIIB080 in Adults 50–80 y with MCI due to Alzheimer’s Disease or Mild AD Dementia
Data & Insights
Has run more than one trial at 56 of 84 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in the clinical research of Alzheimer's disease and its various manifestations, with particular emphasis on early intervention strategies.
- Mild Cognitive Impairment (MCI)
- Early-stage Alzheimer's Disease
- Moderate Alzheimer's Disease Dementia
The research focus includes cognitive assessment and therapeutic approaches for patients aged 50 to 80 years.
Cognitive Assessment
Expertise in evaluating cognitive function through standardized measurement tools and clinical assessment methods.
- Clinical Dementia Rating-Sum of Boxes (CDR-SB)
- Cognitive Decline Monitoring
- Treatment Response Assessment
Specializes in longitudinal cognitive assessment over extended treatment periods.
Therapeutic Approaches
Investigates diverse therapeutic interventions for neurodegenerative conditions.
- Novel Therapeutic Compounds
- Cerebrospinal Fluid-Based Treatments
- Alternative Treatment Strategies
Focuses on both conventional and innovative treatment methodologies for cognitive disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.